Clinical Trial Update: Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a three-drug regimen of oxaliplatin, capecitabine, and Endostar as first-line therapy for advanced colorectal cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Endostar (recombinant human endostatin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: UNKNOWN